Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: HCT Cash-Only INcentive to Promote Mealtime Insulin DOSE Engagement [NA]

View source ↗

Summary

Completed clinical trial evaluating a cash incentive to promote engagement with mealtime insulin dosing in children with Type 1 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Type 1 Diabetes | NA | Status: COMPLETED